They are provided to help interpret the literature, not as a protocol for human use, and cagrilintide in particular has no approved dose for any application
GLP-1 medications slow gastric emptying and affect gut motility, which can cause nausea, diarrhoea, constipation, and bloating
While the FD&C Act provides the framework for drug approval and regulation in the U.S., the current trend of using Ozempic for weight loss demonstrates how consumer behavior can sometimes outpace regulatory intent
If you are considering switching due to plateau, exploring why you are not losing weight on your current medication may reveal other factors at play
In 2020, Valle-Gonzalez and colleagues applied a glycolic acid formula at pH 34.5 and showed it was antibacterial against the acne-forming bacteria C